Cerebral Interferon Entry in Mice after Osmotic Alteration of Blood–Brain Barrier
- 1 June 1989
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon Research
- Vol. 9 (3) , 353-362
- https://doi.org/10.1089/jir.1989.9.353
Abstract
Systemically administered interferon (IFN) is not readily detected in the central nervous system (CNS) due to the presence of the blood-brain barrier (BBB). A method of osmotic BBB alteration in a mouse model was established in this laboratory. IFN''s entry into the normal and osmotically altered brain after its intracarotid injection was investigated. Significant IFN levels (100-1,000 units) in the brain can be achieved by this method. The highest IFN activity was found in the brain hemisphere ipsilateral to the injection site within 20 min to 1 h after injection. IFN activity in the brain was detectable up to 4 h. Animals injected in this manner with murine IFN-.alpha./.beta. (MuIFN-.alpha./.beta.) and observed for a 6-month time interval showed no signs of neurological dysfunctions and resumed their normal activities. The therapeutic value of this method will be tested in a murine model of malignant glioma.This publication has 37 references indexed in Scilit:
- Intrathecally Administered Natural Human Fibroblast Interferon Reduces Exacerbations of Multiple SclerosisArchives of Neurology, 1987
- Antitumor Effect of Recombinant Murine Interferon-β against Mouse Malignant GliomaJournal of Interferon Research, 1987
- Pharmacokinetics of Recombinant Interferon-α2 Following Intralesional Administration in Malignant Glioma PatientsJournal of Interferon Research, 1987
- Phase II trial of interferon-β for treatment of recurrent glioblastoma multiformeJournal of Neurosurgery, 1986
- Immunobiology of primary intracranial tumorsJournal of Neurosurgery, 1985
- Clinical effect of interferon in malignant brain tumoursNeurosurgical Review, 1984
- Evaluation of Routes of Administration of Interferon in Cancer: A Review and a ProposalCancer Drug Delivery, 1984
- Effect of human leukocyte interferon on malignant brain tumorsCancer, 1983
- Block of a glioma cell line in S by interferonInternational Journal of Cancer, 1981
- Pharmacology of interferons I. pharmacologic distinctions between human leukocyte and fibroblast interferonsInternational Journal of Immunopharmacology, 1979